Roth David - Insider Non-Derivative Transactions at Syros Pharmaceuticals, Inc. (SYRS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 18, 2024, Roth David's relationship to Syros Pharmaceuticals, Inc. (SYRS) is Officer (Chief Medical Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SYRS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Roth David - Insider Non-Derivative Transactions of SYRS Common Stock

Roth David - Insider Non-Derivative Transactions at SYRS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 19, 2024	Sell -- (Common Stock)	12099	0.2	0
Nov 1, 2024	F -- (Common Stock)	6776	2.09	12099
Nov 1, 2024	M -- (Common Stock)	18875	0	18875
Apr 4, 2024	Sell -- (Common Stock)	10451	4.95	0
Apr 3, 2024	Sell -- (Common Stock)	150	4.98	10451
Apr 2, 2024	F -- (Common Stock)	4732	5.12	10601
Apr 1, 2024	M -- (Common Stock)	2000	0	2000
Apr 1, 2024	M -- (Common Stock)	13333	0	15333
Dec 13, 2023	Sell -- (Common Stock)	6287	4.95	0
Dec 7, 2023	Sell -- (Common Stock)	6287	3.95	6287
Nov 2, 2023	F -- (Common Stock)	6301	2.22	12574
Nov 1, 2023	M -- (Common Stock)	18875	0	18875
Aug 1, 2023	Sell -- (Common Stock)	7348	3.95	0
Apr 4, 2023	F -- (Common Stock)	623	2.58	7348
Apr 1, 2023	M -- (Common Stock)	2000	0	7971